GlassScriptPhysician profile
Lavinia Mitulescu
NPI 1205122579
$12,612.53
in general payments reported to CMS, 2019-2025
11 companies · $99.43 in 2025
The $99.43 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,249 · 2020: $5,207 · 2021: $211 · 2022: $3,815 · 2023: $14.50 · 2024: $16.05 · 2025: $99.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $129.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $5,484.16 | 2019-2020 | |
| Abbott Laboratories | $4,342.09 | 2020-2025 | Mitraclip |
| Siemens Medical Solutions USA, INC. | $1,821.93 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $388.68 | 2019-2022 | |
| Abiomed | $140.49 | 2022 | |
| Shockwave Medical, INC | $136.26 | 2022 | |
| Amgen INC. | $100.21 | 2022 | |
| Medtronic, INC. | $79.34 | 2021-2025 | Corevalve Evolut R |
| Boston Scientific Corporation | $66.82 | 2022 | |
| Novartis Pharmaceuticals Corporation | $38.05 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $14.50 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lavinia Mitulescu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.